Waldburg-Zeil Akutkliniken GmbH & Co. KG

At Waldburg-Zeil Akutkliniken GmbH & Co. KG in Wangen, the Klinik für Pneumologie is conducting research in respiratory tract diseases focused on improving care for people with chronic and serious lung conditions. The trials explore both infection control in airway disease and treatment strategies for advanced lung cancer.

• Studies in bronchiectasis are evaluating inhalation-based therapy to help clear Pseudomonas aeruginosa from the airways and improve infection-related outcomes.
• Research in respiratory tract diseases also looks at better ways to manage persistent airway infection and support long-term lung health.
• The purpose of this work is to test new approaches that may improve symptom control, reduce bacterial persistence, and strengthen treatment effectiveness in chronic lung disease.

The site’s small but focused program reflects a clear interest in practical, patient-centered advances for everyday pulmonary care.

Clinical research at this hospital also covers neoplasms, with a strong focus on non-small cell lung cancer. These studies are designed to assess whether targeted treatment combinations can offer better disease control than standard chemotherapy for patients with advanced cancer.

• Trials in non-small cell lung cancer are examining treatment options for patients with EGFR-mutated disease and MET-related tumor changes.
• The main goal is to compare a targeted therapy approach with conventional cancer treatment to see which strategy better delays disease progression.
• This line of research aims to improve outcomes for people with locally advanced or metastatic lung cancer after prior treatment has stopped working.

At Waldburg-Zeil Akutkliniken GmbH & Co. KG, the oncology work is centered on finding more effective options for difficult-to-treat lung tumors while supporting more personalized care.